2021
DOI: 10.1016/j.ijpharm.2020.120033
|View full text |Cite
|
Sign up to set email alerts
|

Assembly strategy of liposome and polymer systems for siRNA delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(26 citation statements)
references
References 113 publications
0
26
0
Order By: Relevance
“…In addition, siRNA complexation with cationic polymers via electrostatic interactions has been largely studied [56][57][58]. However, this approach suffers from some limitations, such as the stability issue in biological fluids, low transfection efficiency, and toxicity problems [45,55,59].…”
Section: Characterization Of Sinrf2-nanobubble Formulationsmentioning
confidence: 99%
“…In addition, siRNA complexation with cationic polymers via electrostatic interactions has been largely studied [56][57][58]. However, this approach suffers from some limitations, such as the stability issue in biological fluids, low transfection efficiency, and toxicity problems [45,55,59].…”
Section: Characterization Of Sinrf2-nanobubble Formulationsmentioning
confidence: 99%
“…Results obtained showed that the encapsulated formulation has higher efficiency than Doxorubicin. [153] The polyphenol drugs Naringenin, Quercetin, and Curcumin were formulated as a cumulative drug delivery carrier using a functionalized nanohybrid hydrogel containing L-Histidine (HIS) conjugated chitosan, phytosynthesized zinc oxide nanoparticles, and dialdehyde cellulose. This system showed higher encapsulation efficiency, sustained drug delivery and higher toxicity towards A431 cells.…”
Section: Chemistryselectmentioning
confidence: 99%
“…The selection of different ligands that are connected with liposomes can be targeted to different receptor-positive targets. The ligands of liposomes can be selected according to the needs of drug administration [ 120 , 121 , 122 ]. Class D systems are integrated therapeutic liposomes composed of nanoparticles, target units and contrast agents.…”
Section: Membrane Proteins and Their Applications In The Treatment Of Diseasesmentioning
confidence: 99%